| Pharmaceutical Information |
| Drug Name |
Rimantadine |
| Drug ID |
BADD_D01944 |
| Description |
An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza. |
| Indications and Usage |
For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
J05AC02 |
| DrugBank ID |
DB00478
|
| KEGG ID |
D08483
|
| MeSH ID |
D012299
|
| PubChem ID |
5071
|
| TTD Drug ID |
D0TQ1G
|
| NDC Product Code |
Not Available |
| Synonyms |
Rimantadine | Remantadine | Riamantadine | Roflual | Flumadine | Rimantadine Hydrochloride | Hydrochloride, Rimantadine |
|
| Chemical Information |
| Molecular Formula |
C12H21N |
| CAS Registry Number |
13392-28-4 |
| SMILES |
CC(C12CC3CC(C1)CC(C3)C2)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Vomiting | 07.01.07.003 | - | - | | | Decreased appetite | 14.03.01.005; 08.01.09.028 | - | - | |
|
|
|
